factual

Blood Biomarker p-tau217 Stages Alzheimer's Risk

A simple, available blood biomarker called p-tau217 (and a couple similar ones) is as good as a brain PET scan for assessing Alzheimer's risk, and by repeating the test over six months to a year it can precisely stage when mild cognitive deficit will appear—a sharp advance over old genetic tests that gave risk extent but not timing.

factualpending

Speaker

Eric Topol

Evidence Quote

“there's a blood Biomarker called P-tau217, and there's a couple others like it. And basically what they are is as good as a PET scan for the brain... it stages the disease, no less makes the diagnosis of risk.”

Source

313 | Eric Topol on the Changing Face of Medicine and Aging— Sean Carroll's Mindscape
Created: 6/13/2026, 12:07:11 AM

Your notes

Loading notes...